Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02772887 · ClinicalTrials.gov registry record · NA
Nutraceutical Citrulline in Pregnancy
A NA study, sponsored by University of Pittsburgh.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02772887: Clinical Trial NA study, sponsored by University of Pittsburgh.
NCT02772887 is a NA study that was terminated before completion, run by University of Pittsburgh. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02772887, a NA study, was terminated before completion, sponsored by University of Pittsburgh.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if oral of L-citrulline (3 grams/day) for 3 weeks provided in mid-pregnancy to pregnant women with type 2 diabetes will increase the plasma L-arginine/ADMA ratio, lower maternal blood pressure and increase maternal levels of placental growth factor (PlGF).
Primary Outcome
research measure
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT L-Citrulline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2016-08 |
| Est. Completion | 2019-05 |
| Phase | NA |
Why NCT02772887 stopped before completion
NCT02772887 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02772887 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02772887 about?
NCT02772887 is a clinical study titled "Nutraceutical Citrulline in Pregnancy". The purpose of this study is to determine if oral of L-citrulline (3 grams/day) for 3 weeks provided in mid-pregnancy to pregnant women with type 2 diabetes will increase the plasma L-arginine/ADMA ratio, lower maternal blood pressure and increase maternal levels of placental growth factor (PlGF).
What is the current status of trial NCT02772887?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2016-08. Estimated completion is 2019-05.
What interventions are being tested in trial NCT02772887?
The interventions under investigation include: Placebo (OTHER), L-Citrulline (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02772887?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02772887's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia